Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang et al. Barbhaiya M, Zuily S, Hendry AM, Manneville F, et al. Ann Rheum Dis 2024;83:e5.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Barbhaiya M, Zuily S, Hendry AM, Manneville F, et al. Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang et al. Ann Rheum Dis 2024;83:e5.
PMID: 37989547